| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/06/2004 | EP1414964A2 Vegf isoform |
| 05/06/2004 | EP1414963A2 Lipid-associated molecules |
| 05/06/2004 | EP1414961A2 Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression |
| 05/06/2004 | EP1414862A1 Anti-idiotypic antibodies of hla class i molecules and the use thereof in the preparation of compositions that are designed to inhibit vascular activation |
| 05/06/2004 | EP1414859A2 Anti-ssrp-1 monoclonal antibodies and hybridomas producing said antibodies |
| 05/06/2004 | EP1414858A2 Single chain camelid vhh antibodies, method for their production in a mammal, and their uses |
| 05/06/2004 | EP1414855A2 Peptide inhibiting platelet derived growth factor (pdgf-bb) and fibroblast growth factor (bfgf) activity |
| 05/06/2004 | EP1414849A2 Immune-modulating peptide |
| 05/06/2004 | EP1414846A2 Molecule |
| 05/06/2004 | EP1414843A1 Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same |
| 05/06/2004 | EP1414841A1 Oligonucleotide-containing pharmacological compositions and their use |
| 05/06/2004 | EP1414837A1 Adenosine a3 receptor agonists |
| 05/06/2004 | EP1414830A1 Tumour inhibiting lanthane compounds |
| 05/06/2004 | EP1414829A2 Tumour inhibiting cerium compounds |
| 05/06/2004 | EP1414828A1 Antitumoral analogs |
| 05/06/2004 | EP1414825A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 05/06/2004 | EP1414817A1 Substituted isoindoles and e use thereof |
| 05/06/2004 | EP1414813A1 1,2,4-trioxolane antimalarials |
| 05/06/2004 | EP1414812A1 Hydroxamic acid derivatives |
| 05/06/2004 | EP1414809A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 05/06/2004 | EP1414808A1 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists |
| 05/06/2004 | EP1414805A1 Indazole or indole derivatives, their use in human medicine and more particularly in cancerology |
| 05/06/2004 | EP1414804A1 Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors |
| 05/06/2004 | EP1414792A1 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates |
| 05/06/2004 | EP1414790A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments |
| 05/06/2004 | EP1414526A2 Antiangiogenic combination therapy for the treatment of cancer |
| 05/06/2004 | EP1414525A2 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-n-methyl-isobutyramide |
| 05/06/2004 | EP1414522A2 Carbonic anhydrase inhibitors |
| 05/06/2004 | EP1414499A2 Non-invasive tumor imaging by tumor-targeted bacteria |
| 05/06/2004 | EP1414498A2 Stabilized formulations of interferons with sulfoalkyl ether cyclodextrins |
| 05/06/2004 | EP1414494A1 Inhibitors of her3 activity |
| 05/06/2004 | EP1414492A1 Method for treating multiple myeloma |
| 05/06/2004 | EP1414486A2 Use of glp-2 in combination with another therapeutic agent in bone-related and nutrition-related disorders |
| 05/06/2004 | EP1414481A2 Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 05/06/2004 | EP1414480A1 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 05/06/2004 | EP1414477A2 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 05/06/2004 | EP1414474A1 High protein, bowman-birk inhibitor concentrate and process for its manufacture |
| 05/06/2004 | EP1414472A1 Method for preparing fetuin and polypeptide to induce apoptosis |
| 05/06/2004 | EP1414471A2 Therapeutic agents comprising pro-apoptotic proteins |
| 05/06/2004 | EP1414465A2 Use of inhibitors of progesterone receptor for treating cancer |
| 05/06/2004 | EP1414456A1 Phenyl derivatives as factor xa inhibitors |
| 05/06/2004 | EP1414455A1 Isoquinoline inhibitors of p38 |
| 05/06/2004 | EP1414450A1 (pyridinyl and pyrimidyl)trienoic acid derivatives as retinoid x receptor modulators |
| 05/06/2004 | EP1414447A1 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 05/06/2004 | EP1414444A1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 05/06/2004 | EP1414443A1 BENZIMIDAZO 4,5-f]ISOQUINOLINONE DERIVATIVES |
| 05/06/2004 | EP1414440A1 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 05/06/2004 | EP1414439A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/06/2004 | EP1414438A1 Antineoplastic combinations |
| 05/06/2004 | EP1414434A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 05/06/2004 | EP1414406A2 A bioactive agent delivering system comprised of microparticules within a biodegradable to improve release profiles |
| 05/06/2004 | EP1414384A2 Synthesis of epothilones and relates analogs |
| 05/06/2004 | EP1414299A2 Substantially homogeneous bio-affecting material having a pre-determined ratio of bioaffecting component to cell targeting component, the method for making such a material and the method of its use |
| 05/06/2004 | EP1369122A4 Anticancer agent |
| 05/06/2004 | EP1325011B1 Methods and compounds for treating proliferative diseases |
| 05/06/2004 | EP1280802B1 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation |
| 05/06/2004 | EP1263753B1 Imidazol derivatives as raf kinase inhibitors |
| 05/06/2004 | EP1261602B1 Imidazol-2-carboxamide derivatives as raf kinase inhibitors |
| 05/06/2004 | EP1227714B1 Method for producing metabolites from plants cultivated in soil-less medium |
| 05/06/2004 | EP1222162B1 Novel ltb4-antagonist, method for the production thereof and its use as a medicament |
| 05/06/2004 | EP1123283B1 Thiazole-derivatives |
| 05/06/2004 | EP1036072B1 Thrombin receptor antagonists |
| 05/06/2004 | EP0968182B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/06/2004 | EP0963998B1 Azasteroid compound for treating or preventing prostatic cancer |
| 05/06/2004 | EP0821696B1 Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use |
| 05/06/2004 | EP0776161B1 Use of a viral vector encoding a cytochrome p450 gene in combination with a chemotherapeutic agent for selectively destroying neoplastic cells |
| 05/06/2004 | CA2510238A1 Cancer treatment using vaccine and high-dose cytokine |
| 05/06/2004 | CA2505597A1 Agent elevating dendritic cell precursor level in blood |
| 05/06/2004 | CA2503457A1 Apparatus and method for immunotherapy of a cancer through controlled cell lysis |
| 05/06/2004 | CA2503245A1 Alkyne derivatives as tracers for metabotropic glutamate receptor binding |
| 05/06/2004 | CA2502960A1 Active specific immunotherapy of cancer metastasis |
| 05/06/2004 | CA2502607A1 Method for treating erectile dysfunction and increasing libido in men |
| 05/06/2004 | CA2502488A1 Novel substituted[1,4]benzodioxino[2,3-e]isoindole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/06/2004 | CA2502484A1 Substituted benzol[e] [1,4] oxazino[3,2-g] isoindole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/06/2004 | CA2500836A1 Metal-containing materials, compositions and methods |
| 05/05/2004 | CN1494591A Polynucleotide useful for modulating cancer cell proliferation |
| 05/05/2004 | CN1494588A Use of protein histidine phosphatase |
| 05/05/2004 | CN1494553A Modified antibodies and method of use |
| 05/05/2004 | CN1494552A Flt 4 (VEGFR-3) as target for tumor imaging and anti-tumor therapy |
| 05/05/2004 | CN1494542A 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 05/05/2004 | CN1494541A Heterocyclic inhibitors of ERK 2 and uses thereof |
| 05/05/2004 | CN1494435A Preparation for prophylaxis of restenosis |
| 05/05/2004 | CN1494433A Use of CD 23 antagonists for treatment of neoplastic disorders |
| 05/05/2004 | CN1494428A Antitumour medicine |
| 05/05/2004 | CN1494425A Carboxamide derivatives as therapeutic agents |
| 05/05/2004 | CN1494423A Benzimidazole derivatives as therapeutic agents |
| 05/05/2004 | CN1493581A EB virus antisense oligomeric deoxynucleotide and its application |
| 05/05/2004 | CN1493360A Preparation method of magnetic guiding anticancer medicine |
| 05/05/2004 | CN1493327A Chinese medicine for treating leucocythemia and its preparation method and application. |
| 05/05/2004 | CN1493326A Returning yang and blood producing pill |
| 05/05/2004 | CN1493322A Chinese medicine composition for treating tumour |
| 05/05/2004 | CN1493312A Chinese medicine for treating liver disease |
| 05/05/2004 | CN1493298A Ginseng stem leaf total saponin drip pill and its preparation method |
| 05/05/2004 | CN1493291A Dicyclic compound capable of inhibiting epidermis growth factor acceptor rotatory tyrosine kinase |
| 05/05/2004 | CN1493289A Hydroxy camptothecin emulsion and its preparation method |
| 05/05/2004 | CN1493288A Hanfangchin A drip pill and its preparation method |
| 05/05/2004 | CN1493279A Norcantharidin drip pill and its preparation method |
| 05/05/2004 | CN1148447C Amino-terminally trancated RANTES as chemokine antagonists |
| 05/05/2004 | CN1148446C Polypeptide bound with MORT-1 and MACH and its DNA sequence, producing method, medical composition and use |
| 05/05/2004 | CN1148381C New human chemotaxis factor macrophage inflammatory protein, its coding sequence and use |